CYTK:NASDAQ
Cytokinetics, Inc.
$64.88
arrow_downward
-1.14%(-0.75) 1D
Oct 2, 12:35:25 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$66.45
High
$66.91
Low
$64.59
Mkt. cap
9.02B
Avg. vol.
2.00M
Volume
651.73K
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$66.45
High
$66.91
Low
$64.59
Mkt. cap
9.02B
Avg. vol.
2.00M
Volume
651.73K
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Zacks
·
3 hours ago
Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?
Yahoo Finance
·
5 hours ago
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
AD HOC NEWS
·
1 day ago
Cytokinetics launches ASPEN-HCM and analysts rate Cytokinetics stock a Buy
Simply Wall Street
·
1 day ago
Is Real World Study Launch Altering The Investment Case For Cytokinetics (CYTK)?
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com